Skip to main content
. 2020 Mar 22;75(7):576–583. doi: 10.1136/thoraxjnl-2018-213021

Table 3.

Expression levels of 16 proteins differentially expressed between TB and non-TB

Proteins Median TB (pg/mL) 25%–75% TB (pg/mL) Median non-TB (pg/mL) 25%–75% non-TB (pg/mL) P value FDR Ratio Cohen's d
MIG 2490.5 1121.3–6512.4 609.2 295.9–1312.9 0 0 0.831 0.226
Furin 0 0–5.697 245.18 10.11–352.18 0 0.001 −2.065 −0.195
I-309 5.792 3.058–10.982 1.9 1.087–3.23 0 0.001 1.389 0.847
IL-1 F7 1785.8 1506.6–2021.3 1321.1 1109.3–1657.4 0 0.002 −0.574 −0.105
EGFR 3242 2786–3775 4246 3478–4935 0 0.002 −0.317 −0.789
I-TAC 100.27 61.11–198.06 48.04 28.84–84.45 0 0.003 0.765 0.513
MEP1B 372.76 28.38–756.09 894.8 413.3–1479.9 0 0.006 −1.273 −0.55
Granulysin 514.38 296.66–837.17 945 555.1–1641.4 0 0.013 −0.664 −0.558
MDGA1 206 117.19–258.77 294.83 186.64–553.11 0 0.017 −1.075 −0.486
FAP 5999 5613–7308 7213 6376–8744 0.001 0.025 −0.246 −0.645
FOLR2 1205.8 929.2–1943.5 880.07 469.61–1224.33 0.001 0.025 0.542 0.663
PDGF-CC 69.78 0–316.87 0 0–70.69 0.001 0.025 0.696 0.189
IGFBP-5 0 0–0 51.04 0–785.55 0 0.025 −4.24 −0.177
LYVE-1 767.2 712.2–917.2 694.8 626.1–768.2 0.001 0.029 0.271 0.824
CRIM1 121.69 90.25–168.92 157.89 113.99–238.47 0.001 0.035 −0.659 −0.572
CHI3L1 2922 2527–3503 2293.6 1714.7–3171.7 0.001 0.035 0.265 0.4

Ratio: log2 (fold change); ratio >0, upregulation in TB; ratio <0, upregulation in non-TB.

CHI3L1, chitinase-3-like protein 1; CRIM1, cysteine rich transmembrane BMP regulator 1; EFGR, epidermal growth factor receptor; IL-1 F7, interleukin-1 family member 7 ; FAP, fibroblast activation protein; FDR, false discovery rate; FOLR2, folate receptor beta; I-309, also called CCL1/TCA3; IGFBP-5, insulin-like growth factor-binding protein 5; I-TAC, interferon-inducible T-cell alpha chemoattractant; LYVE1, lymphatic vessel endothelial hyaluronan receptor 1; MDGA1, MAM domain containing glycosylphosphatidylinositol anchor1; MEP1B, meprin A subunit beta; MIG, monokine induced by gamma interferon; PDGF-CC, platelet-derived growth factor-CC.